New Cancer Treatments Approved in Canada: Bexxar (Tositumomab), Zevalin (Ibritumomab Tiuxetan), and Avastin
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive